Mutations in isocitrate dehydrogenase (IDH1) and isocitrate dehydrogenase 2 (IDH2) represent a different group of cancer-related genetic alterations responsible for regulating the activity of α-ketoglutarate-dependent-dioxygenases [5]. Here, IDH2 is linked to cancer.